RadNet (RDNT) Competitors $76.52 -1.46 (-1.87%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends RDNT vs. NTRA, LH, DGX, EXAS, GH, VCYT, FTRE, VRDN, CDNA, and CSTLShould you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Natera (NTRA), Laboratory Co. of America (LH), Quest Diagnostics (DGX), Exact Sciences (EXAS), Guardant Health (GH), Veracyte (VCYT), Fortrea (FTRE), Viridian Therapeutics (VRDN), CareDx (CDNA), and Castle Biosciences (CSTL). These companies are all part of the "medical laboratories" industry. RadNet vs. Natera Laboratory Co. of America Quest Diagnostics Exact Sciences Guardant Health Veracyte Fortrea Viridian Therapeutics CareDx Castle Biosciences RadNet (NASDAQ:RDNT) and Natera (NASDAQ:NTRA) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, community ranking, valuation, institutional ownership, media sentiment, profitability and dividends. Does the MarketBeat Community believe in RDNT or NTRA? Natera received 129 more outperform votes than RadNet when rated by MarketBeat users. Likewise, 68.82% of users gave Natera an outperform vote while only 66.04% of users gave RadNet an outperform vote. CompanyUnderperformOutperformRadNetOutperform Votes35066.04% Underperform Votes18033.96% NateraOutperform Votes47968.82% Underperform Votes21731.18% Which has more volatility and risk, RDNT or NTRA? RadNet has a beta of 1.77, suggesting that its share price is 77% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Which has stronger valuation & earnings, RDNT or NTRA? RadNet has higher revenue and earnings than Natera. RadNet is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRadNet$1.77B3.19$3.04M-$0.07-1,093.14Natera$1.08B20.51-$434.80M-$1.76-95.57 Do analysts prefer RDNT or NTRA? RadNet currently has a consensus target price of $84.75, indicating a potential upside of 10.76%. Natera has a consensus target price of $152.67, indicating a potential downside of 9.24%. Given RadNet's stronger consensus rating and higher possible upside, equities research analysts clearly believe RadNet is more favorable than Natera.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RadNet 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Natera 0 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of RDNT or NTRA? 77.9% of RadNet shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Comparatively, 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Is RDNT or NTRA more profitable? RadNet has a net margin of -0.25% compared to Natera's net margin of -14.01%. RadNet's return on equity of 4.29% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets RadNet-0.25% 4.29% 1.45% Natera -14.01%-26.23%-14.27% Does the media refer more to RDNT or NTRA? In the previous week, Natera had 16 more articles in the media than RadNet. MarketBeat recorded 19 mentions for Natera and 3 mentions for RadNet. RadNet's average media sentiment score of 1.63 beat Natera's score of 0.70 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Natera 10 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryRadNet beats Natera on 11 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get RadNet News Delivered to You Automatically Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDNT vs. The Competition Export to ExcelMetricRadNetMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.66B$2.93B$5.19B$9.32BDividend YieldN/A11.01%4.78%4.06%P/E Ratio-1,092.9916.26128.2217.54Price / Sales3.19210.801,259.00139.66Price / Cash24.19472.0941.2237.95Price / Book6.495.224.884.92Net Income$3.04M-$32.86M$119.69M$225.78M7 Day Performance-5.05%-2.24%16.64%-1.56%1 Month Performance-3.25%10.39%16.32%6.68%1 Year Performance113.15%17.34%35.37%22.48% RadNet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDNTRadNet4.0338 of 5 stars$76.52-1.9%$84.75+10.8%+110.5%$5.66B$1.77B-1,092.9910,288Positive NewsNTRANatera2.1102 of 5 stars$167.04+0.3%$152.67-8.6%+185.1%$22.05B$1.53B-94.633,293LHLaboratory Co. of America4.9758 of 5 stars$230.87-0.5%$257.67+11.6%+5.2%$19.31B$12.71B44.8867,000Analyst ForecastPositive NewsDGXQuest Diagnostics4.8482 of 5 stars$154.27-0.5%$168.92+9.5%+15.2%$17.22B$9.54B20.8348,000Analyst UpgradeEXASExact Sciences4.6063 of 5 stars$60.68-0.9%$72.94+20.2%-8.4%$11.23B$2.50B-52.356,600GHGuardant Health3.8131 of 5 stars$35.13+1.1%$40.60+15.6%+23.6%$4.34B$692.26M-8.201,779News CoveragePositive NewsVCYTVeracyte4.1747 of 5 stars$43.35+0.3%$41.13-5.1%+49.9%$3.36B$361.05M-288.13790Positive NewsFTREFortrea2.2351 of 5 stars$20.15+0.8%$23.30+15.6%-39.0%$1.81B$3.11B-5.8518,000VRDNViridian Therapeutics2.9656 of 5 stars$22.50+26.1%$36.33+61.5%+8.3%$1.78B$310,000.00-5.2950Analyst ForecastNews CoverageGap UpHigh Trading VolumeCDNACareDx3.7677 of 5 stars$22.68-0.8%$29.60+30.5%+122.1%$1.22B$280.32M-8.35740Short Interest ↑News CoverageCSTLCastle Biosciences2.6486 of 5 stars$28.77-0.3%$39.71+38.0%+40.2%$805.76M$311.88M144.35540Short Interest ↑ Related Companies and Tools Related Companies Natera Alternatives Laboratory Co. of America Alternatives Quest Diagnostics Alternatives Exact Sciences Alternatives Guardant Health Alternatives Veracyte Alternatives Fortrea Alternatives Viridian Therapeutics Alternatives CareDx Alternatives Castle Biosciences Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RDNT) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
